| Literature DB >> 28600334 |
Alan D Michelson1, Deepak L Bhatt2.
Abstract
Antiplatelet therapy is of proven benefit in coronary artery disease and a number of other clinical settings. This article reviews platelet function, molecular targets of antiplatelet agents, and clinical indications for antiplatelet therapy before focusing on a frequent question to hematologists about the 2 most commonly used antiplatelet therapies: Could the patient be aspirin "resistant" or clopidogrel "resistant"? If so, should results of a platelet function test be used to guide the dose or type of antiplatelet therapy? Whether such guided therapy is of clinical benefit to patients has been a source of controversy. The present article reviews this subject in the context of 2 prototypical clinical cases. Available evidence does not support the use of laboratory tests to guide the dose of aspirin or clopidogrel in patients with so-called aspirin or clopidogrel "resistance."Entities:
Mesh:
Substances:
Year: 2017 PMID: 28600334 DOI: 10.1182/blood-2017-03-742338
Source DB: PubMed Journal: Blood ISSN: 0006-4971 Impact factor: 22.113